Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 112

1.

Minimizing General Anesthetic Use in Pediatric Radiation Therapy.

Ntoukas SM, Ritchie T, Awrey S, Hodgson DC, Laperriere N, Yee R, Ramaswamy V, Millar BA, Becker N, Tsang DS.

Pract Radiat Oncol. 2019 Dec 10. pii: S1879-8500(19)30365-0. doi: 10.1016/j.prro.2019.12.001. [Epub ahead of print]

PMID:
31841675
2.

Re-irradiation for children with recurrent medulloblastoma in Toronto, Canada: a 20-year experience.

Tsang DS, Sarhan N, Ramaswamy V, Nobre L, Yee R, Taylor MD, Hawkins C, Bartels U, Huang A, Tabori U, Hodgson DC, Bouffet E, Laperriere N.

J Neurooncol. 2019 Oct;145(1):107-114. doi: 10.1007/s11060-019-03272-2. Epub 2019 Aug 29.

PMID:
31468270
3.

Response-adapted therapy for the treatment of children with newly diagnosed high risk Hodgkin lymphoma (AHOD0831): a report from the Children's Oncology Group.

Kelly KM, Cole PD, Pei Q, Bush R, Roberts KB, Hodgson DC, McCarten KM, Cho SY, Schwartz C.

Br J Haematol. 2019 Oct;187(1):39-48. doi: 10.1111/bjh.16014. Epub 2019 Jun 10.

PMID:
31180135
4.

Cost-Effectiveness of Colonoscopy-Based Colorectal Cancer Screening in Childhood Cancer Survivors.

Gini A, Meester RGS, Keshavarz H, Oeffinger KC, Ahmed S, Hodgson DC, Lansdorp-Vogelaar I.

J Natl Cancer Inst. 2019 Nov 1;111(11):1161-1169. doi: 10.1093/jnci/djz060.

5.

Meningioma Screening With MRI in Childhood Leukemia Survivors Treated With Cranial Radiation.

Co JL, Swain M, Murray LJ, Ahmed S, Laperriere NJ, Tsang DS, Yu E, Pintilie M, Weiss J, Hodgson DC.

Int J Radiat Oncol Biol Phys. 2019 Jul 1;104(3):640-643. doi: 10.1016/j.ijrobp.2019.02.057. Epub 2019 Mar 14.

PMID:
30880270
6.

Salvage Treatment and Survival for Relapsed Follicular Lymphoma Following Primary Radiation Therapy: A Collaborative Study on Behalf of ILROG.

Binkley MS, Brady JL, Hajj C, Chelius M, Chau K, Balogh A, Levis M, Filippi AR, Jones M, Ahmed S, MacManus M, Wirth A, Oguchi M, Vistisen AK, Andraos TY, Ng AK, Aleman BMP, Choi SH, Kirova YM, Hardy S, Reinartz G, Eich HT, Bratman SV, Constine LS, Suh CO, Dabaja B, El-Galaly TC, Hodgson DC, Ricardi U, Yahalom J, Mikhaeel NG, Hoppe RT.

Int J Radiat Oncol Biol Phys. 2019 Jul 1;104(3):522-529. doi: 10.1016/j.ijrobp.2019.03.004. Epub 2019 Mar 8.

PMID:
30858143
7.

Effect of PET/CT on the Management and Outcomes of Participants with Hodgkin and Aggressive Non-Hodgkin Lymphoma: A Multicenter Registry.

Metser U, Prica A, Hodgson DC, Mozuraitis M, Eberg M, Mak V, Green B, Singnurkar A, Dudebout J, MacCrostie P, Tau N, Mittmann N, Langer DL.

Radiology. 2019 Feb;290(2):488-495. doi: 10.1148/radiol.2018181519. Epub 2018 Dec 4.

PMID:
30511907
8.

Definitive radiotherapy for localized follicular lymphoma staged by 18F-FDG PET-CT: a collaborative study by ILROG.

Brady JL, Binkley MS, Hajj C, Chelius M, Chau K, Balogh A, Levis M, Filippi AR, Jones M, Mac Manus M, Wirth A, Oguchi M, Vistisen AK, Andraos TY, Ng AK, Aleman BMP, Choi SH, Kirova Y, Hardy S, Reinartz G, Eich HT, Bratman SV, Constine LS, Suh CO, Dabaja B, El-Galaly TC, Hodgson DC, Ricardi U, Yahalom J, Hoppe RT, Mikhaeel NG.

Blood. 2019 Jan 17;133(3):237-245. doi: 10.1182/blood-2018-04-843540. Epub 2018 Nov 16. Erratum in: Blood. 2019 Jul 18;134(3):331.

9.

Risk, Risk Factors, and Surveillance of Subsequent Malignant Neoplasms in Survivors of Childhood Cancer: A Review.

Turcotte LM, Neglia JP, Reulen RC, Ronckers CM, van Leeuwen FE, Morton LM, Hodgson DC, Yasui Y, Oeffinger KC, Henderson TO.

J Clin Oncol. 2018 Jul 20;36(21):2145-2152. doi: 10.1200/JCO.2017.76.7764. Epub 2018 Jun 6. Review.

10.

The Role of Radiation Therapy in Patients With Relapsed or Refractory Hodgkin Lymphoma: Guidelines From the International Lymphoma Radiation Oncology Group.

Constine LS, Yahalom J, Ng AK, Hodgson DC, Wirth A, Milgrom SA, Mikhaeel NG, Eich HT, Illidge T, Ricardi U, Dieckmann K, Moskowitz CH, Advani R, Mauch PM, Specht L, Hoppe RT.

Int J Radiat Oncol Biol Phys. 2018 Apr 1;100(5):1100-1118. doi: 10.1016/j.ijrobp.2018.01.011. Epub 2018 Jan 9. Review.

11.

Early-stage Hodgkin lymphoma in the modern era: simulation modelling to delineate long-term patient outcomes.

Parsons SK, Kelly MJ, Cohen JT, Castellino SM, Henderson TO, Kelly KM, Keller FG, Henzer TJ, Kumar AJ, Johnson P, Meyer RM, Radford J, Raemaekers J, Hodgson DC, Evens AM.

Br J Haematol. 2018 Jul;182(2):212-221. doi: 10.1111/bjh.15255. Epub 2018 Apr 29.

12.

Beyond Expert Opinion: Progress in the Development of Evidence-Based Screening Guidelines for Survivors of Childhood Cancer.

Hodgson DC, Henderson TO.

J Natl Cancer Inst. 2018 Jul 1;110(7):694-695. doi: 10.1093/jnci/djy007. No abstract available.

PMID:
29529217
13.

Ovarian function after chemotherapy in young breast cancer survivors.

Morarji K, McArdle O, Hui K, Gingras-Hill G, Ahmed S, Greenblatt EM, Warner E, Sridhar S, Ali AMF, Azad A, Hodgson DC.

Curr Oncol. 2017 Dec;24(6):e494-e502. doi: 10.3747/co.24.3335. Epub 2017 Dec 20.

14.

Proton therapy in mediastinal Hodgkin lymphoma: moving from dosimetric prediction to clinical evidence.

Ricardi U, Dabaja B, Hodgson DC.

Ann Oncol. 2017 Sep 1;28(9):2049-2050. doi: 10.1093/annonc/mdx356. No abstract available.

15.

Monte Carlo-driven predictions of neurocognitive and hearing impairments following proton and photon radiotherapy for pediatric brain-tumor patients.

Fortin D, Tsang D, Ng A, Laperriere N, Hodgson DC.

J Neurooncol. 2017 Dec;135(3):521-528. doi: 10.1007/s11060-017-2597-3. Epub 2017 Aug 19.

PMID:
28825228
16.

Best Practice Recommendations for the Retention of Radiotherapy Records.

Lockhart E, Bak K, Schreiner LJ, Hodgson DC, Gutierrez E, Warde P, Sharpe MB.

Clin Oncol (R Coll Radiol). 2017 Nov;29(11):e195-e202. doi: 10.1016/j.clon.2017.06.013. Epub 2017 Aug 12.

PMID:
28811150
17.

Variant histology, IgD and CD30 expression in low-risk pediatric nodular lymphocyte predominant Hodgkin lymphoma: A report from the Children's Oncology Group.

Untanu RV, Back J, Appel B, Pei Q, Chen L, Buxton A, Hodgson DC, Ehrlich PF, Constine LS, Schwartz CL, Hutchison RE.

Pediatr Blood Cancer. 2018 Jan;65(1). doi: 10.1002/pbc.26753. Epub 2017 Aug 12.

18.

[18 F]-FDG PET/CT in the staging and management of indolent lymphoma: A prospective multicenter PET registry study.

Metser U, Dudebout J, Baetz T, Hodgson DC, Langer DL, MacCrostie P, Mak V, Tau N.

Cancer. 2017 Aug 1;123(15):2860-2866. doi: 10.1002/cncr.30672. Epub 2017 Mar 13.

19.

Stomach Cancer Following Hodgkin Lymphoma, Testicular Cancer and Cervical Cancer: A Pooled Analysis of Three International Studies with a Focus on Radiation Effects.

Gilbert ES, Curtis RE, Hauptmann M, Kleinerman RA, Lynch CF, Stovall M, Smith SA, Weathers R, Andersson M, Dores GM, Fraumeni JF Jr, Fossa SD, Hall P, Hodgson DC, Holowaty EJ, Joensuu H, Johannesen TB, Langmark F, Kaijser M, Pukkala E, Rajaraman P, Storm HH, Vaalavirta L, van den Belt-Dusebout AW, Aleman BM, Travis LB, Morton LM, van Leeuwen FE.

Radiat Res. 2017 Feb;187(2):186-195. doi: 10.1667/RR14453.1. Epub 2017 Jan 24.

20.

Predictive Factor Analysis of Response-Adapted Radiation Therapy for Chemotherapy-Sensitive Pediatric Hodgkin Lymphoma: Analysis of the Children's Oncology Group AHOD 0031 Trial.

Charpentier AM, Friedman DL, Wolden S, Schwartz C, Gill B, Sykes J, Albert-Green A, Kelly KM, Constine LS, Hodgson DC.

Int J Radiat Oncol Biol Phys. 2016 Dec 1;96(5):943-950. doi: 10.1016/j.ijrobp.2016.07.015.

21.

High prevalence of adenomatous colorectal polyps in young cancer survivors treated with abdominal radiation therapy: results of a prospective trial.

Daly PE, Samiee S, Cino M, Gryfe R, Pollett A, Ng A, Constine LS, Hodgson DC.

Gut. 2017 Oct;66(10):1797-1801. doi: 10.1136/gutjnl-2016-311501. Epub 2016 Jul 13.

PMID:
27411369
22.

ACR Appropriateness Criteria® Hodgkin Lymphoma-Unfavorable Clinical Stage I and II.

Roberts KB, Younes A, Hodgson DC, Advani R, Dabaja BS, Dhakal S, Flowers CR, Ha CS, Hoppe BS, Mendenhall NP, Metzger ML, Plastaras JP, Shapiro R, Smith SM, Terezakis SA, Winkfield KM, Constine LS; Expert Panel on Radiation OncologyLymphoma.

Am J Clin Oncol. 2016 Aug;39(4):384-95. doi: 10.1097/COC.0000000000000294. Review.

PMID:
27299425
23.

Minimal Treatment of Low-Risk, Pediatric Lymphocyte-Predominant Hodgkin Lymphoma: A Report From the Children's Oncology Group.

Appel BE, Chen L, Buxton AB, Hutchison RE, Hodgson DC, Ehrlich PF, Constine LS, Schwartz CL.

J Clin Oncol. 2016 Jul 10;34(20):2372-9. doi: 10.1200/JCO.2015.65.3469. Epub 2016 May 16.

24.

A Comparative Evaluation of Normal Tissue Doses for Patients Receiving Radiation Therapy for Hodgkin Lymphoma on the Childhood Cancer Survivor Study and Recent Children's Oncology Group Trials.

Zhou R, Ng A, Constine LS, Stovall M, Armstrong GT, Neglia JP, Friedman DL, Kelly K, FitzGerald TJ, Hodgson DC.

Int J Radiat Oncol Biol Phys. 2016 Jun 1;95(2):707-11. doi: 10.1016/j.ijrobp.2016.01.053. Epub 2016 Feb 4.

25.

Impact of Early Breast Cancer Screening on Mortality Among Young Survivors of Childhood Hodgkin's Lymphoma.

Hodgson DC, Cotton C, Crystal P, Nathan PC.

J Natl Cancer Inst. 2016 Mar 1;108(7). doi: 10.1093/jnci/djw010. Print 2016 Jul. Erratum in: J Natl Cancer Inst. 2016 Apr;108(4). pii: djw102. doi: 10.1093/jnci/djw102.

PMID:
26933010
26.

ACR Appropriateness Criteria® Diffuse Large B-Cell Lymphoma.

Dabaja BS, Advani R, Hodgson DC, Dhakal S, Flowers CR, Ha CS, Hoppe BS, Mendenhall NP, Metzger ML, Plastaras JP, Roberts KB, Shapiro R, Smith SM, Terezakis SA, Winkfield KM, Younes A, Constine LS.

Am J Clin Oncol. 2015 Dec;38(6):610-20. doi: 10.1097/COC.0000000000000215. Review.

PMID:
26583344
27.

Consolidative Radiation in DLBCL: Evidence-Based Recommendations.

Hodgson DC, Mikhaeel NG.

Curr Oncol Rep. 2015 Nov;17(11):49. doi: 10.1007/s11912-015-0472-y. Review.

PMID:
26373412
28.

Current knowledge and future research directions in treatment-related second primary malignancies.

Morton LM, Swerdlow AJ, Schaapveld M, Ramadan S, Hodgson DC, Radford J, van Leeuwen FE.

EJC Suppl. 2014 Jun;12(1):5-17. doi: 10.1016/j.ejcsup.2014.05.001. Epub 2014 May 29.

29.

Echocardiographic Detection of Cardiac Dysfunction in Childhood Cancer Survivors: How Long Is Screening Required?

Ramjaun A, AlDuhaiby E, Ahmed S, Wang L, Yu E, Nathan PC, Hodgson DC.

Pediatr Blood Cancer. 2015 Dec;62(12):2197-203. doi: 10.1002/pbc.25651. Epub 2015 Jul 6. Erratum in: Pediatr Blood Cancer. 2017 Mar;64(3):.

30.

Clinical characteristics and early treatment outcomes of follicular lymphoma in young adults.

Gangatharan SA, Maganti M, Kuruvilla JG, Kukreti V, Tiedemann RE, Gospodarowicz MK, Hodgson DC, Sun A, Tsang RW, Pintilie M, Crump M.

Br J Haematol. 2015 Aug;170(3):384-90. doi: 10.1111/bjh.13451. Epub 2015 Apr 22.

PMID:
25904266
31.

Current approaches in the management of low risk Hodgkin lymphoma in children and adolescents.

Giulino-Roth L, Keller FG, Hodgson DC, Kelly KM.

Br J Haematol. 2015 Jun;169(5):647-60. doi: 10.1111/bjh.13372. Epub 2015 Mar 30. Review.

PMID:
25824371
32.
33.

Implementation of contemporary radiation therapy planning concepts for pediatric Hodgkin lymphoma: Guidelines from the International Lymphoma Radiation Oncology Group.

Hodgson DC, Dieckmann K, Terezakis S, Constine L; International Lymphoma Radiation Oncology Group.

Pract Radiat Oncol. 2015 Mar-Apr;5(2):85-92. doi: 10.1016/j.prro.2014.05.003. Epub 2014 Jul 9.

PMID:
25413415
34.

The effect of radiation quality on the risks of second malignancies.

Manem VS, Kohandel M, Hodgson DC, Sharpe MB, Sivaloganathan S.

Int J Radiat Biol. 2015 Mar;91(3):209-17. doi: 10.3109/09553002.2014.980466. Epub 2015 Jan 24.

PMID:
25356906
35.

ACR appropriateness criteria follow-up of Hodgkin lymphoma.

Ha CS, Hodgson DC, Advani R, Dabaja BS, Dhakal S, Flowers CR, Hoppe BS, Mendenhall NP, Metzger ML, Plastaras JP, Roberts KB, Shapiro R, Smith S, Terezakis SA, Winkfield KM, Younes A, Constine LS.

J Am Coll Radiol. 2014 Nov;11(11):1026-1033.e3. doi: 10.1016/j.jacr.2014.07.038. Epub 2014 Sep 30.

PMID:
25278496
36.

Risk of esophageal cancer following radiotherapy for Hodgkin lymphoma.

Morton LM, Gilbert ES, Stovall M, van Leeuwen FE, Dores GM, Lynch CF, Hall P, Smith SA, Weathers RE, Storm HH, Hodgson DC, Kleinerman RA, Joensuu H, Johannesen TB, Andersson M, Holowaty EJ, Kaijser M, Pukkala E, Vaalavirta L, Fossa SD, Langmark F, Travis LB, Lamart S, Simon SL, Fraumeni JF Jr, Aleman BM, Curtis RE.

Haematologica. 2014 Oct;99(10):e193-6. doi: 10.3324/haematol.2014.108258. No abstract available.

37.

Pancreatic cancer risk after treatment of Hodgkin lymphoma.

Dores GM, Curtis RE, van Leeuwen FE, Stovall M, Hall P, Lynch CF, Smith SA, Weathers RE, Storm HH, Hodgson DC, Kleinerman RA, Joensuu H, Johannesen TB, Andersson M, Holowaty EJ, Kaijser M, Pukkala E, Vaalavirta L, Fossa SD, Langmark F, Travis LB, Fraumeni JF Jr, Aleman BM, Morton LM, Gilbert ES.

Ann Oncol. 2014 Oct;25(10):2073-9. doi: 10.1093/annonc/mdu287. Epub 2014 Jul 25.

38.

Low-dose chest computed tomography for lung cancer screening among Hodgkin lymphoma survivors: a cost-effectiveness analysis.

Wattson DA, Hunink MG, DiPiro PJ, Das P, Hodgson DC, Mauch PM, Ng AK.

Int J Radiat Oncol Biol Phys. 2014 Oct 1;90(2):344-53. doi: 10.1016/j.ijrobp.2014.06.013. Epub 2014 Aug 4.

PMID:
25104066
39.

Breast cancer detection among young survivors of pediatric Hodgkin lymphoma with screening magnetic resonance imaging.

Tieu MT, Cigsar C, Ahmed S, Ng A, Diller L, Millar BA, Crystal P, Hodgson DC.

Cancer. 2014 Aug 15;120(16):2507-13. doi: 10.1002/cncr.28747. Epub 2014 May 28.

40.

Anti-Müllerian hormone screening to assess ovarian reserve among female survivors of childhood cancer.

Charpentier AM, Chong AL, Gingras-Hill G, Ahmed S, Cigsar C, Gupta AA, Greenblatt E, Hodgson DC.

J Cancer Surviv. 2014 Dec;8(4):548-54. doi: 10.1007/s11764-014-0364-4. Epub 2014 May 9.

PMID:
24810980
41.

Active breathing control for patients receiving mediastinal radiation therapy for lymphoma: Impact on normal tissue dose.

Charpentier AM, Conrad T, Sykes J, Ng A, Zhou R, Parent A, Coolens C, Tsang RW, Gospodarowicz MK, Sun A, Hodgson DC.

Pract Radiat Oncol. 2014 May-Jun;4(3):174-180. doi: 10.1016/j.prro.2013.07.015. Epub 2013 Sep 16.

PMID:
24766684
42.

ACR Appropriateness Criteria Pediatric Hodgkin Lymphoma.

Terezakis SA, Metzger ML, Hodgson DC, Schwartz CL, Advani R, Flowers CR, Hoppe BS, Ng A, Roberts KB, Shapiro R, Wilder RB, Yunes MJ, Constine LS.

Pediatr Blood Cancer. 2014 Jul;61(7):1305-12. doi: 10.1002/pbc.24983. Epub 2014 Feb 24. Review.

PMID:
24616347
43.

Stratification of treatment intensity in relapsed pediatric Hodgkin lymphoma.

Harker-Murray PD, Drachtman RA, Hodgson DC, Chauvenet AR, Kelly KM, Cole PD.

Pediatr Blood Cancer. 2014 Apr;61(4):579-86. doi: 10.1002/pbc.24851. Epub 2013 Nov 8. Review.

PMID:
24504790
44.

ACR Appropriateness Criteria: Localized nodal indolent lymphoma.

Hoppe BS, Hodgson DC, Advani R, Dabaja BS, Flowers CR, Ha CS, Metzger ML, Plastaras JP, Roberts KB, Shapiro R, Terezakis SA, Winkfield KM, Younes A, Constine LS.

Oncology (Williston Park). 2013 Aug;27(8):786-94. Review.

45.

Stomach cancer risk after treatment for hodgkin lymphoma.

Morton LM, Dores GM, Curtis RE, Lynch CF, Stovall M, Hall P, Gilbert ES, Hodgson DC, Storm HH, Johannesen TB, Smith SA, Weathers RE, Andersson M, Fossa SD, Hauptmann M, Holowaty EJ, Joensuu H, Kaijser M, Kleinerman RA, Langmark F, Pukkala E, Vaalavirta L, van den Belt-Dusebout AW, Fraumeni JF Jr, Travis LB, Aleman BM, van Leeuwen FE.

J Clin Oncol. 2013 Sep 20;31(27):3369-77. doi: 10.1200/JCO.2013.50.6832. Epub 2013 Aug 26.

46.

Role of comparative effectiveness research in cancer funding decisions in Ontario, Canada.

Hoch JS, Hodgson DC, Earle CC.

J Clin Oncol. 2012 Dec 1;30(34):4262-6. doi: 10.1200/JCO.2012.42.1958. Epub 2012 Oct 15. Review.

PMID:
23071242
47.

Cancer screening practices of cancer survivors: population-based, longitudinal study.

Grunfeld E, Moineddin R, Gunraj N, Del Giudice ME, Hodgson DC, Kwon JS, Elit L.

Can Fam Physician. 2012 Sep;58(9):980-6.

48.

Individualized 3D reconstruction of normal tissue dose for patients with long-term follow-up: a step toward understanding dose risk for late toxicity.

Ng A, Brock KK, Sharpe MB, Moseley JL, Craig T, Hodgson DC.

Int J Radiat Oncol Biol Phys. 2012 Nov 15;84(4):e557-63. doi: 10.1016/j.ijrobp.2012.06.026. Epub 2012 Aug 25.

PMID:
22929861
49.

Impact of low-dose involved-field radiation therapy on pediatric patients with lymphocyte-predominant Hodgkin lymphoma treated with chemotherapy: a report from the Children's Oncology Group.

Appel BE, Chen L, Buxton A, Wolden SL, Hodgson DC, Nachman JB.

Pediatr Blood Cancer. 2012 Dec 15;59(7):1284-9. doi: 10.1002/pbc.24258. Epub 2012 Jul 27.

50.

Limited-stage mantle cell lymphoma: treatment outcomes at the Princess Margaret Hospital.

Bernard M, Tsang RW, Le LW, Hodgson DC, Sun A, Wells W, Kukreti V, Kuruvilla J, Crump M, Gospodarowicz MK.

Leuk Lymphoma. 2013 Feb;54(2):261-7. doi: 10.3109/10428194.2012.711828. Epub 2012 Sep 10.

PMID:
22793378

Supplemental Content

Loading ...
Support Center